Clinical trial · Observational
Linear Source Registry for Prostate Cancer
CivaString Registry for Prostate Cancer
NCT02516709CI-TRIAL-00069459CaRePCcompletedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Ongoing follow up for subjects implanted with the Linear Source String for prostate cancer.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Prostate Cancer | Malignant Prostate Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Linear LDR Source | Radiation | — | UNRESOLVED |
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Biochemical Response Rate (PSA)
- timeFrame
- Up to 5 years
Secondary outcomes (2)
- measure
- Side Effects (IPSS, IIEF, RFAS score)
- timeFrame
- Up to 5 years
- measure
- Adverse Events
- timeFrame
- Up to 5 years
Eligibility
Eligibility (as posted)
- Sex
- Male
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Age \> 18 years old * Plans to remain in care of enrolling physician for 5 years * \> 5 years life expectancy * Signed informed consent * Enrolled within 6 weeks of implant or within 365 days of prior implant Exclusion Criteria: * Not willing or able to comply with protocol visit schedule
References
Publications (0)
Data not yet available
No reference posted for this study.